Peter Adamietz

1.9k total citations
37 papers, 1.4k citations indexed

About

Peter Adamietz is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Peter Adamietz has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Peter Adamietz's work include PARP inhibition in cancer therapy (20 papers), Toxin Mechanisms and Immunotoxins (10 papers) and Osteoarthritis Treatment and Mechanisms (7 papers). Peter Adamietz is often cited by papers focused on PARP inhibition in cancer therapy (20 papers), Toxin Mechanisms and Immunotoxins (10 papers) and Osteoarthritis Treatment and Mechanisms (7 papers). Peter Adamietz collaborates with scholars based in Germany and United States. Peter Adamietz's co-authors include Helmuth Hilz, N. M. Meenen, Christiane Goepfert, Ralf Pörtner, Anny Rudolph, Klaus Wielckens, U. Wiegers, Reinhard Bredehorst, Werner Fanick and R Bredehorst and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Peter Adamietz

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Adamietz Germany 20 691 541 242 219 211 37 1.4k
Lizabeth A. Bourret United States 13 554 0.8× 206 0.4× 164 0.7× 120 0.5× 99 0.5× 18 1.3k
Stacy Porvasnik United States 21 505 0.7× 218 0.4× 116 0.5× 332 1.5× 135 0.6× 47 1.3k
Stephen N. Mueller United States 20 927 1.3× 181 0.3× 97 0.4× 234 1.1× 264 1.3× 28 1.9k
Iñigo Martínez Norway 15 361 0.5× 195 0.4× 72 0.3× 160 0.7× 152 0.7× 22 1.1k
L Weir United States 12 1.2k 1.8× 184 0.3× 95 0.4× 344 1.6× 374 1.8× 14 2.0k
Joseph Leighton United States 22 853 1.2× 378 0.7× 338 1.4× 342 1.6× 109 0.5× 79 1.9k
Zena K. Indik United States 29 882 1.3× 122 0.2× 195 0.8× 75 0.3× 689 3.3× 47 2.1k
Glenn D. Papworth United States 22 1.3k 1.9× 182 0.3× 218 0.9× 379 1.7× 917 4.3× 25 2.4k
Frances B. Cannon United States 7 933 1.4× 339 0.6× 246 1.0× 230 1.1× 194 0.9× 7 2.1k
Brad Zerler United States 19 1.3k 1.8× 724 1.3× 287 1.2× 143 0.7× 201 1.0× 25 2.2k

Countries citing papers authored by Peter Adamietz

Since Specialization
Citations

This map shows the geographic impact of Peter Adamietz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Adamietz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Adamietz more than expected).

Fields of papers citing papers by Peter Adamietz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Adamietz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Adamietz. The network helps show where Peter Adamietz may publish in the future.

Co-authorship network of co-authors of Peter Adamietz

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Adamietz. A scholar is included among the top collaborators of Peter Adamietz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Adamietz. Peter Adamietz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goepfert, Christine, et al.. (2010). Cartilage Engineering from Mesenchymal Stem Cells. PubMed. 123. 163–200. 20 indexed citations
2.
Ueblacker, Peter, Christine Goepfert, Peter Adamietz, et al.. (2007). Long term results after implantation of tissue engineered cartilage for the treatment of osteochondral lesions in a minipig model. Journal of Materials Science Materials in Medicine. 19(5). 2029–2038. 46 indexed citations
3.
Goepfert, Christiane, et al.. (2005). Bioreactor cultivation of three-dimensional cartilage-carrier-constructs. Bioprocess and Biosystems Engineering. 27(4). 273–280. 25 indexed citations
4.
Goepfert, Christiane, et al.. (2005). Cultivation of three-dimensional cartilage-carrier-constructs under reduced oxygen tension. Journal of Biotechnology. 121(4). 486–497. 12 indexed citations
5.
Pörtner, Ralf, et al.. (2005). Bioreactor design for tissue engineering. Journal of Bioscience and Bioengineering. 100(3). 235–245. 194 indexed citations
6.
Stute, Norbert, Boris Fehse, Jens‐Michael Schröder, et al.. (2002). Human Mesenchymal Stem Cells Are Not of Donor Origin in Patients with Severe Aplastic Anemia Who Underwent Sex-Mismatched Allogeneic Bone Marrow Transplant. Journal of Hematotherapy & Stem Cell Research. 11(6). 977–984. 28 indexed citations
7.
Meyer, J., Alfred Jonczyk, Horst Kessler, et al.. (2002). RGD-peptides for tissue engineering of articular cartilage. Biomaterials. 23(16). 3455–3463. 111 indexed citations
8.
Adamietz, Peter, et al.. (1998). [Treatment of cartilage defects].. PubMed. 115. 568–76. 5 indexed citations
9.
Meenen, N. M., et al.. (1993). Der Effekt von synthetischer Hydroxylapatitkeramik auf Langzeitkulturen isolierter Chondrozyten. European Journal of Trauma. 19(5). 257–266. 5 indexed citations
10.
Adamietz, Peter, et al.. (1993). A simple mechanical procedure of produce encapsulated cells. Nucleic Acids Research. 21(18). 4408–4409. 2 indexed citations
11.
Adamietz, Peter. (1987). Poly(ADP-ribose) synthase is the major endogenous nonhistone acceptor for poly(ADP-ribose) in alkylated rat hepatoma cells. European Journal of Biochemistry. 169(2). 365–372. 54 indexed citations
12.
Adamietz, Peter, et al.. (1985). Alkylation-Induced Mono(ADP-ribosyl)-Histones H1 and H2B. Hydroxylamine-Resistant Linkage in Hepatoma Cells. Biological Chemistry Hoppe-Seyler. 366(1). 537–544. 16 indexed citations
13.
Adamietz, Peter & Helmuth Hilz. (1984). [48] Purification and characterization of (ADP-ribosyl)n proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 106. 461–471. 3 indexed citations
14.
Hilz, Helmuth, et al.. (1984). Nonenzymic ADP-ribosylation of specific mitochondrial polypeptides.. Proceedings of the National Academy of Sciences. 81(13). 3929–3933. 63 indexed citations
15.
Wielckens, Klaus, R Bredehorst, Peter Adamietz, & Helmuth Hilz. (1982). Mono ADP-ribosylation and poly ADP-ribosylation of proteins in normal and malignant tissues. Advances in Enzyme Regulation. 20. 23–37. 15 indexed citations
16.
Adamietz, Peter, et al.. (1981). Subcellular distribution of mono(ADP-ribose) protein conjugates in rat liver. Biochemical and Biophysical Research Communications. 101(1). 96–103. 31 indexed citations
17.
Adamietz, Peter, et al.. (1979). Isolation and partial characterization of the ADP-ribosylated nuclear proteins from Ehrlich ascites tumor cells. Biochemical and Biophysical Research Communications. 91(4). 1232–1238. 41 indexed citations
18.
Hilz, Helmuth, Peter Adamietz, Reinhard Bredehorst, & Klaus Wielckens. (1979). ADP-ribosylation of nuclear proteins. Advances in Enzyme Regulation. 17. 195–211. 13 indexed citations
19.
Adamietz, Peter, et al.. (1975). Seminar on Poly(ADP-Ribose) and ADP-ribosylation of Protine. The Journal of Biochemistry. 77(supp1). 4–4. 8 indexed citations
20.
Adamietz, Peter, et al.. (1975). Proceedings: Is poly(ADP-ribose) covalently bound to nuclear proteins?. PubMed. 77(1?). 4p–4p. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026